Cas:873225-46-8 IKK-16 manufacturer & supplier

Chemical Name:IKK-16

CAS.NO:873225-46-8

Synonyms:IKK Inhibitor VII;IN1460;IKK Inhibitor;(4-{[4-(1-Benzothiophen-2-yl)-2-pyrimidinyl]amino}phenyl)[4-(1-pyrrolidinyl)-1-piperidinyl]methanone;(4-{[4-(1-benzothiophen-2-yl)pyrimidin-2-yl]amino}phenyl)[4-(pyrrolidin-1-yl)piperidin-1-yl]methanone;IKK-16 (IKK Inhibitor VII);Methanone, [4-[(4-benzo[b]thien-2-yl-2-pyrimidinyl)amino]phenyl][4-(1-pyrrolidinyl)-1-piperidinyl]-;IKK-16;CS-1282;HMS3229F15;IKK 16

Molecular Formula:C₂₈H₂₉N₅OS

Molecular Weight:483.628

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:721.6±70.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.700

PSA:89.60000

Exact Mass:483.209290

LogP:5.67

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like IKK Inhibitor VII chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,IKK 16 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,IKK Inhibitor VII Use and application,CS-1282 technical grade,usp/ep/jp grade.

Related News: The Company��s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs). IKK-16 manufacturer Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities. IKK-16 supplier Any South Korean citizen returning home who has been in Hubei Province within the past two weeks will be subject to 14 days of self-quarantine and monitoring, the government said. IKK-16 vendor The Company��s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs). IKK-16 factory Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.